Hepatitis Viruses: The Natural History of Infection

  • Jinah Choi
  • Jing-hsiung Ou


Hepatitis viruses are important human pathogens that affect millions of people worldwide. These viruses, as their names imply, cause inflammation of the liver and therefore, were mainly identified for their shared abilities to cause transmissible hepatitis in human. During the last several decades, studies have revealed the diverse molecular nature of these viruses that, in turn, have greatly aided their control by various preventative and therapeutic measures. However, despite our concerted efforts to control and eradicate them, hepatitis viruses remain as one of the major challenges to scientific and health communities worldwide.


Hepatitis Delta Virus Hepatitis Delta Virus Infection Acute Yellow Atrophy Transmit Hepatitis Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cockayne E.A. Catarrhal jaundice, sporadic and epidemic, and its relation to acute yellow atrophy of the liver. Q J Med 1912; 6:1–29.Google Scholar
  2. 2.
    Findlay G.M., Dunlop J.L., Brown H.C. Observations on epidemic catarrhal jaundice. Trans R Soc Trop Med Hyg 1931; 25:7–24.Google Scholar
  3. 3.
    McDonald S. Acute yellow atrophy of the liver. Edin Med J 1908; 1:83–88.Google Scholar
  4. 4.
    Lurman A. Eine icterusepidemie. Bed Klin Wochenschr 1885; 22:20.Google Scholar
  5. 5.
    Anonymous. Homologous serum hepatitis. Lancet 1947; ii:691–692.Google Scholar
  6. 6.
    Krugman S., Giles J.P., and Hammond J. Infectious hepatitis, Evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA 1967; 200:365–373.PubMedGoogle Scholar
  7. 7.
    MacCallum F.O. Homologous serum jaundice. Lancet 1947; 2:691.Google Scholar
  8. 8.
    Purcell R.H. The discovery of the hepatitis viruses. Gastroenterology 1993; 104:955–963.PubMedGoogle Scholar
  9. 9.
    Francki R.I.B., Fauquet C.M., Knudson D.L., Brown F. Classification of nomenclature of viruses. Fifth report of the International Committee on Taxonomy of Viruses. Arch Virol 1991; 2(Suppl): 320–326.Google Scholar
  10. 10.
    Blumberg B.S. The nature of Australia antigen: infectious and genetic characteristics. Prog Liver Dis 1972; 4:367–379.PubMedGoogle Scholar
  11. 11.
    Blumberg B.S., Gerstley B.J., Hungerford D.A., London W.T., Sutnick A.I. A serum antigen (Australia antigen) in Down’s syndrome, leukemia, and hepatitis. Ann Intern Med 1967; 66:924–931.PubMedGoogle Scholar
  12. 12.
    Dane D.S., Cameron C.H., Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis, Lancet 1970; 1:695–698.PubMedGoogle Scholar
  13. 13.
    Galibert F., Chen T. N., Mandait E. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J Virol 1982; 41:51–65.PubMedGoogle Scholar
  14. 14.
    Seeger C., Ganem D., Varmus H.E. Nucleotide sequence of an infectious molecularly cloned genome of ground squirrel hepatitis virus. J Virol 1984; 51:367–375.PubMedGoogle Scholar
  15. 15.
    Mason W.S., Seal G., Summers J. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol 1980; 36:829–836.PubMedGoogle Scholar
  16. 16.
    Rizzetto M., Canese M.G., Arico S., Crivelli O., Trepo C., Bonino F., Verme G. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977; 18:997–1003.PubMedGoogle Scholar
  17. 17.
    Lai, M.M. Molecular biologic and pathogenetic analysis of hepatitis delta virus. J Hepatol 1995; 22:127–131.PubMedGoogle Scholar
  18. 18.
    Diener T.O. Viroid replication. New York: Plenum, 1987; pp 117–166.Google Scholar
  19. 19.
    Balayan M.S., Andjaparidze A.G., Savinskaya S.S., Ketiladze E.S., Braginsky D.M., Savinov A.P., Poleschuk V.F. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983; 20:23–31.PubMedGoogle Scholar
  20. 20.
    Kane M.A., Bradley D.W., Shrestha S.M., Maynard J.E., Cook E.H., Mishra R.P., Joshi D.D. Epidemic non-A, non-B hepatitis in Nepal. Recovery of a possible etiologic agent and transmission studies in marmosets. JAMA 1984; 252:3140–3145.PubMedGoogle Scholar
  21. 21.
    Reyes G.R., Purdy M.A., Kim J.P., Luk K.C., Young L.M., Fry K.E., Bradley D.W. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990; 247:1335–1339.PubMedGoogle Scholar
  22. 22.
    Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359–362.PubMedGoogle Scholar
  23. 23.
    Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P.J., et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88:2451–2455.PubMedGoogle Scholar
  24. 24.
    Bowden S. New hepatitis viruses: contenders and pretenders. J Gastroenterol Hepatol 2001; 16:124–31.PubMedGoogle Scholar
  25. 25.
    Gimenez-Barcons M., Forns X., Ampurdanes S., Guilera M., Soler M., Soguero C., Sanchez-Fueyo A., Mas A., Bruix J., Sanchez-Tapias J. M., Rodes J., Saiz J.C. Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases. J Hepatol 1999; 30:1028–1034.PubMedGoogle Scholar
  26. 26.
    Karayiannis P. Thomas H.C. Hepatitis G virus: identification and prevalence. Br J Hosp Med 1996; 56:238–240.PubMedGoogle Scholar
  27. 27.
    Nishizawa T., Okamoto H., Konishi K., Yoshizawa H., Miyakawa Y., Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology, Biochem Biophys Res Commun 1997; 241:92–97.PubMedGoogle Scholar
  28. 28.
    Zuckerman A.J. The acronym TTV. Transfusion transmitted virus. Lancet 1999; 353:932.PubMedGoogle Scholar
  29. 29.
    Tanaka Y., Primi D., Wang R.Y., Umemura T., Yeo A.E., Mizokami M., Alter H.J., Shih J.W. Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family, J Infect Dis 2001; 183:359–367.PubMedGoogle Scholar
  30. 30.
    Umemura T., Yeo A. E., Sottini A., Moratto D., Tanaka Y., Wang R. Y., Shih J. W., Donahue P., Primi D., Alter H. J. SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology 2001; 33:1303–1311.PubMedGoogle Scholar
  31. 31.
    Cheng Y., Zhang W., Li J., Li B., Zhao J., Gao R., Xin S., Mao P., Cao Y. Serological and histological findings in infection and transmission of GBV-C/HGV to macaques. J Med Virol 2000; 60:28–33.PubMedGoogle Scholar
  32. 32.
    Schaluder G.G., Dawson G.J., Simons J.N., Pilot-Matias T.J., Gutierrez R.A., Heynen C.A., Knigge M.F., Kurpiewski G.S., Buijk S.L., Leary T.P., et al. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol 1995;46:81–90.PubMedGoogle Scholar
  33. 33.
    Beames B., Chavez D., Guerra B., Notvall L., Brasky K.M., Lanford R.E. Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus. J Virol 2000; 74:11764–11772.PubMedGoogle Scholar
  34. 34.
    Havens W.P.J., Ward R., Drill V.A., Paul J.R. Experimental production of hepatitis by feeding icterogenic materials. Proc Soc Exp Biol Med 1944; 57:206–208.Google Scholar
  35. 35.
    Lemon S.M. Type A viral hepatitis: epidemiology, diagnosis, and prevention. Clin Chem 1997; 43:1494–499.PubMedGoogle Scholar
  36. 36.
    Koff R.S. Hepatitis A. Lancet 1998; 351:1643–1649.PubMedGoogle Scholar
  37. 37.
    Francis D.P., Hadler S.C., Prendergast T.J., Peterson E., Ginsberg M.M., Lookabaugh C., Holmes J.R., Maynard J.E. Occurrence of hepatitis A, B, and non-A/non-B in the United States. CDC sentinel county hepatitis study I. Am J Med 1984; 76:69–74.PubMedGoogle Scholar
  38. 38.
    Hadler S.C., Webster H.M., Erben J.J., Swanson J.E., Maynard J. E. Hepatitis A in day-care centers. A community-wide assessment. N Engl J Med 1980; 302:1222–1227.PubMedGoogle Scholar
  39. 39.
    Cuthbert J.A. Hepatitis A: old and new. Clin Microbiol Rev 2001; 14:38–58.PubMedGoogle Scholar
  40. 40.
    Hutin Y.J., Pool V., Cramer E.H., Nainan O.V., Weth J., Williams I.T., Goldstein S.T., Gensheimer K.F., Bell B.P., Shapiro C.N., Alter M.J., Margolis H.S. A multistate, foodborne outbreak of hepatitis A. National Hepatitis A Investigation Team. N Engl J Med 1999; 340:595–602.PubMedGoogle Scholar
  41. 41.
    Henkel J. Food firm gets huge fine for tainted strawberry harvest, FDA Consum 1999; 33:37–38.PubMedGoogle Scholar
  42. 42.
    Bloch A.B., Stramer S.L., Smith J.D., Margolis H.S., Fields H.A., McKinley T.W., Gerba C.P., Maynard J.E., Sikes R.K. Recovery of hepatitis A virus from a water supply responsible for a common source outbreak of hepatitis A. Am J Public Health 1990; 80:428–430.PubMedGoogle Scholar
  43. 43.
    De Serres G. Laliberte D. Hepatitis A among workers from a waste water treatment plant during a small community outbreak. Occup Environ Med 1997; 54:60–62.PubMedGoogle Scholar
  44. 44.
    Trout D., Mueller C., Venczel L., Krake A. Evaluation of occupational transmission of hepatitis A virus among wastewater workers. J Occup Environ Med 2000; 42:83–87.PubMedGoogle Scholar
  45. 45.
    Goodman R.A. Nosocomial hepatitis A. Ann Intern Med 1985; 103:452–454.PubMedGoogle Scholar
  46. 46.
    Burkholder B.T., Coronado V.G., Brown J., Hutto J.H., Shapiro C.N., Robertson B., Woodruff B.A. Nosocomial transmission of hepatitis A in a pediatric hospital traced to an anti-hepatitis A virus-negative patient with immunodeficiency. Pediatr Infect Dis J 1995; 14:261–266.PubMedGoogle Scholar
  47. 47.
    Irshad M. Hepatitis E virus: an update on its molecular, clinical and epidemiological characteristics. Intervirology 1999; 42:252–262.PubMedGoogle Scholar
  48. 48.
    Harrison T.J. Hepatitis E virus — an update. Liver 1999; 19:171–176.PubMedGoogle Scholar
  49. 49.
    Corwin A., Jarot K., Lubis I., Nasution K., Suparmawo S., Sumardiati A., Widodo S., Nazir S., Orndorff G., Choi Y., et al. Two years’ investigation of epidemic hepatitis E virus transmission in West Kalimantan (Borneo), Indonesia. Trans R Soc Trop Med Hyg 1995; 89:262–265.PubMedGoogle Scholar
  50. 50.
    Drabick J.J., Gambel J.M., Gouvea V.S., Caudill J.D., Sun W., Hoke CH., Jr., Innis B.L. A cluster of acute hepatitis E infection in United Nations Bangladeshi peacekeepers in Haiti. Am J Trop Med Hyg 1997; 57:449–454.PubMedGoogle Scholar
  51. 51.
    Mast E.E. Krawczynski K. Hepatitis E: an overview. Annu Rev Med 1996; 47:257–266.PubMedGoogle Scholar
  52. 52.
    De Cock K.M., Bradley D.W., Sandford N.L., Govindarajan S., Maynard J.E., Redeker A.G. Epidemic non-A, non-B hepatitis in patients from Pakistan, Ann Intern Med 1987; 106:227–230.PubMedGoogle Scholar
  53. 53.
    Center for Disease Control and Prevention. Hepatitis E among U.S. travelers, 1989–1992. Morb Mortal Wkly Rep 1993; 42:1–4.Google Scholar
  54. 54.
    Wu J.C, Sheen I.J., Chiang T.Y., Sheng W.Y., Wang Y.J., Chan C.Y., Lee S.D. The impact of traveling to endemic areas on the spread of hepatitis E virus infection: epidemiological and molecular analyses. Hepatology 1998; 27:1415–1420.PubMedGoogle Scholar
  55. 55.
    Dawson G.J., Chau K.H., Cabal CM., Yarbough P.O., Reyes G.R., Mushahwar I.K. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods 1992; 38:175–186.PubMedGoogle Scholar
  56. 56.
    Kwo P.Y., Schlauder G.G., Carpenter H.A., Murphy P.J., Rosenblatt J.E., Dawson G.J., Mast E.E., Krawczynski K., Balan V. Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc 1997; 72:1133–1136.PubMedGoogle Scholar
  57. 57.
    Mast E.E., Kuramoto I.K., Favorov M.O., Schoening V.R., Burkholder B.T., Shapiro C.N., Holland P.V. Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California. J Infect Dis 1997; 176:34–40.PubMedGoogle Scholar
  58. 58.
    Thomas D.L., Yarbough P.O., Vlahov D., Tsarev S.A., Nelson K.E., Saah A.J., Purcell R.H. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997; 35:1244–1247.PubMedGoogle Scholar
  59. 59.
    Meng X.J., Purcell R.H., Halbur P.G., Lehman J.R., Webb D.M., Tsareva T.S., Haynes J.S., Thacker B.J., Emerson S.U. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 1997; 94:9860–9865.Google Scholar
  60. 60.
    Meng X.J., Halbur P.G., Shapiro M.S., Govindarajan S., Bruna J.D., Mushahwar I.K., Purcell R.H., Emerson S.U. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol 1998; 72:9714–9721.Google Scholar
  61. 61.
    Noble R.C., Kane M.A., Reeves S.A., Roeckel I. Posttransfusion hepatitis A in a neonatal intensive care unit. JAMA 1984; 252:2711–2715.PubMedGoogle Scholar
  62. 62.
    Meyers J.D., Huff J.C., Holmes K.K., Thomas E.D., Bryan J.A. Parenterally transmitted hepatitis A associated with platelet transfusions. Epidemiologic study of an outbreak in a marrow transplantation center. Ann Intern Med 1974; 81:145–151.PubMedGoogle Scholar
  63. 63.
    Weisfuse I.B., Graham D.J., Will M., Parkinson D., Snydman D.R., Atkins M., Karron R.A., Feinstone S., Rayner A.A., Fisher R.I., et al. An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cells, J Infect Dis 1990; 161: 647–652.PubMedGoogle Scholar
  64. 64.
    Zanetti A.R. Dawson G.J. Hepatitis type E in Italy: a seroepidemiological survey. Study Group of Hepatitis E. J Med Virol 1994; 42:318–320.Google Scholar
  65. 65.
    Grinde B., Stene-Johansen K., Sharma B., Hoel T., Jensenius M., Skaug K. Characterisation of an epidemic of hepatitis A virus involving intravenous drug abusers—infection by needle sharing?. J Med Virol 1997; 53:69–75.PubMedGoogle Scholar
  66. 66.
    Zuckerman A.J. More than third of world’s population has been infected with hepatitis B virus. BMJ 1999; 318:1213.PubMedGoogle Scholar
  67. 67.
    Lee W.M. Hepatitis B virus infection. N Engl J Med 1997; 337:1733–1745.PubMedGoogle Scholar
  68. 68.
    Boag F. Hepatitis B: heterosexual transmission and vaccination strategies. Int J STD AIDS 1991;2:318–324.PubMedGoogle Scholar
  69. 69.
    Margolis H.S., Alter M.J., Hadler S.C. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991; 11:84–92.PubMedGoogle Scholar
  70. 70.
    Gust I.D. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 1996; 38:S18–23.PubMedGoogle Scholar
  71. 71.
    Maddrey W.C. Hepatitis B: an important public health issue. J Med Virol 2000; 61:362–366.PubMedGoogle Scholar
  72. 72.
    McQuilla, G.M., Coleman P.J., Kruszon-Moran D., Moyer L.A., Lambert S.B., Margolis H.S. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999; 89:14–18.Google Scholar
  73. 73.
    Rizzetto M., Ponzetto A., Forzani I. Epidemiology of hepatitis delta virus: overview, Prog Clin Biol Res 1991; 364:1–20.PubMedGoogle Scholar
  74. 74.
    Polish L.B., Gallagher M., Fields H.A., Hadler S.C. Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev 1993; 6:211–229.PubMedGoogle Scholar
  75. 75.
    Lange W.R., Cone E.J., Snyder F.R. The association of hepatitis delta virus and hepatitis B virus in parenteral drug abusers. 1971 to 1972 and 1986 to 1987. Arch Intern Med 1990; 150:365–368.PubMedGoogle Scholar
  76. 76.
    Mandelli C., Cesana M., Ferroni P., Lorini G.P., Aimo G.P., Tagger A., Bianchi P. A., Conte D. HBV, HDV and HIV infections in 242 drug addicts: two-year follow-up. Eur J Epidemiol 1988; 4:318–321.PubMedGoogle Scholar
  77. 77.
    Becherer P.R., Wang J.G., White G.C., Lesesne H., Janco R.L., Hanna W.T., Davis C., Johnson C.A., Poon M.C., Andes A., Lemon S.M. “Hepatitis delta virus infection in hemophiliacs.” In Viral hepatitis and liver disease, Hollinger F.B., Lemon S.M., Margolis H.S., eds., Baltimore: The Williams & Wilkins Co., pp 492–494.Google Scholar
  78. 78.
    Hadler S.C., De Monzon M., Ponzetto A., Anzola E., Rivero D., Mondolfi A., Bracho A., Francis D.P., Gerber M.A., Thung S., et al. Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. 1984; Ann Intern Med 100:339–344.Google Scholar
  79. 79.
    Bensabath G., Hadler S.C., Soares M.C., Fields H., Dias L.B., Popper H., Maynard J.E. Hepatitis delta virus infection and Labrea hepatitis. Prevalence and role in fulminant hepatitis in the Amazon Basin. JAMA 1987; 258: 479–483.PubMedGoogle Scholar
  80. 80.
    World Health Organization. Hepatitis C-global prevalence (update). Weekly Epidemiological Record 2000; 75:18–19.Google Scholar
  81. 81.
    Abdel-Wahab M.F., Zakaria S., Kamel M., Abdel-Khaliq M.K., Mabrouk M.A., Salama H., Esmat G., Thomas D.L., Strickland G.T. High seroprevalence of hepatitis C infection among risk groups in Egypt. Am J Trop Med Hyg 1994; 51:563–567.PubMedGoogle Scholar
  82. 82.
    Arthur R.R., Hassan N.F., Abdallah M.Y., el-Sharkawy M.S., Saad M.D., Hackbart B.G., Imam I.Z. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans R Soc Trop Med Hyg 1997; 91:271–274.PubMedGoogle Scholar
  83. 83.
    Thomas D.L., Astemborski J., Rai R.M., Anania F.A., Schaeffer M., Galai N., Nolt K., Nelson K.E., Strathdee S.A., Johnson L., Laeyendecker O., Boitnott J., Wilson L.E., Vlahov D. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284:450–456.PubMedGoogle Scholar
  84. 84.
    McQuillan G.M., Alter M.J., Moyer L.A., Lambert S.B., Margolis H.S. “A population based serologic study of hepatitis C virus infection in the United States.” In Viral hepatitis and liver disease, Rizzetto M., Purcell R.H., Gerin J.L., Venne G., eds., Turin: Edizioni Minerva Medica, 1997; pp 267–270.Google Scholar
  85. 85.
    Alter M.J. Epidemiology of hepatitis C. Hepatology 1997; 26:62S–65S.PubMedGoogle Scholar
  86. 86.
    Center for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morb Mortal Wkly Rep 1998; 47(RR19):1–39.Google Scholar
  87. 87.
    Blajchman M.A., Bull S.B., Feinman S.V. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group. Lancet 1995; 345:21–25.PubMedGoogle Scholar
  88. 88.
    Donahue J.G., Munoz A., Ness P.M., Brown D.E., Jr., Yawn D.H., McAllister H.A., Jr., Reitz B.A., Nelson K.E. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327:369–373.PubMedGoogle Scholar
  89. 89.
    Pereira B.J., Milford E.L., Kirkman R.L., Quan S., Sayre K.R., Johnson P.J., Wilber J.C., Levey A.S. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992; 327:910–915.PubMedGoogle Scholar
  90. 90.
    Schreiber G.B., Busch M.P., Kleinman S.H., Korelitz J.J. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334:1685–1690.PubMedGoogle Scholar
  91. 91.
    Bresee J.S., Mast E.E., Coleman P.J., Baron M.J., Schönberger L.B., Alter M.J., Jonas M.M., Yu M.Y., Renzi P.M., Schneider L.C. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study. JAMA 1996; 276:1563–1567.PubMedGoogle Scholar
  92. 92.
    Capelli C., Prati D., Bosoni P., Zanuso F., Pappalettera M., Mozzi F., De Mattei C., Zanella A., Sirchia G. Sexual transmission of hepatitis C virus to a repeat blood donor. Transfusion. 1997; 37:436–440.PubMedGoogle Scholar
  93. 93.
    Thomas D.L., Zenilman J.M., Alter H.J., Shih J.W., Galai N., Carella A.V., Quinn T.C. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore—an analysis of 309 sex partnerships. J Infect Dis 1995; 171:768–775.PubMedGoogle Scholar
  94. 94.
    Zanetti A.R., Tanzi E., Paccagnini S., Principi N., Pizzocolo G., Caccamo M.L., D’Amico E., Cambie G., Vecchi L. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet 1995; 345:289–291.PubMedGoogle Scholar
  95. 95.
    Mitsui T., Iwano K., Masuko K., Yamazaki C., Okamoto H., Tsuda F., Tanaka T., Mishiro S. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 1992; 16:1109–1114.PubMedGoogle Scholar
  96. 96.
    Wasley A. Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20:1–16.PubMedGoogle Scholar
  97. 97.
    Wong J.B., McQuillan G.M., McHutchison J.G., Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90:1562–1569.PubMedGoogle Scholar
  98. 98.
    Guadagnino V., StrofTolini T., Rapicetta M., Costantino A., Kondili L.A., Menniti-Ippolito F., Caroleo B., Costa C., Griffo G., Loiacono L., Pisani V., Foca A., Piazza M. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997; 26:1006–1011.PubMedGoogle Scholar
  99. 99.
    Morrow R.H., Jr., Smetana H.F., Sai F.T., Edgcomb J.H. Unusual features of viral hepatitis in Accra, Ghana. Ann Intern Med 1968; 68:1250-1264.PubMedGoogle Scholar
  100. 100.
    Khuroo M.S. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980; 68:818–824.PubMedGoogle Scholar
  101. 101.
    Labrique A.B., Thomas D.L., Stoszek S.K., Nelson K.E. Hepatitis E: an emerging infectious disease. Epidemiol Rev 1999; 21:162–179.PubMedGoogle Scholar
  102. 102.
    Arora N.K., Nanda S.K., Gulati S., Ansari L.H., Chawla M.K., Gupta S.D., Panda S.K. Acute viral hepatitis types E, A, and B singly and in combination in acute liver failure in children in north India. J Med Virol 1996; 48:215–221.PubMedGoogle Scholar
  103. 103.
    Bryan J.P., Tsarev S.A., Iqbal M., Ticehurst J., Emerson S., Ahmed A., Duncan J., Rafiqui A.R., Malik I.A., Purcell R.H., et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis 1994; 170:517–521.PubMedGoogle Scholar
  104. 104.
    Huo T.I., Wu J.C., Chiu C.F., Lee S.D. Severe hyperbilirubinemia due to acute hepatitis A superimposed on a chronic hepatitis B carrier with glucose-6-phosphate dehydrogenase deficiency. Am J Gastroenterol 1996; 91:158–159.PubMedGoogle Scholar
  105. 105.
    Tsega E., Hansson B.G., Krawczynski K., Nordenfeit E. Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy. Clin Infect Dis 1992; 14:961–965.PubMedGoogle Scholar
  106. 106.
    Khuroo M.S., Saleem M., Teli M.R., Sofi M.A. Failure to detect chronic liver disease after epidemic non-A, non-B hepatitis. Lancet 1980; 2:97–98.PubMedGoogle Scholar
  107. 107.
    Provost P.J. Hilleman M.R. Propagation of human hepatitis A virus in cell culture in vitro. Proc Soc Exp Biol Med 1979; 160:213–221.PubMedGoogle Scholar
  108. 108.
    Fleischer B., Fleischer S., Maier K., Wiedmann K.H., Sacher M., Thaler H., Vallbracht A. Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology 1990; 69:14–19.PubMedGoogle Scholar
  109. 109.
    National Institutes of Health. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 1997; 26:2S–10S.Google Scholar
  110. 110.
    Lee W.M. Acute liver failure. N Engl J Med 1993; 329:1862–1872.PubMedGoogle Scholar
  111. 111.
    McMahon B.J., Alberts S.R., Wainwright R.B., Bulkow L., Lanier A.P. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 1990; 150:1051–1054.PubMedGoogle Scholar
  112. 112.
    Alter M.J. Epidemiology of hepatitis C. Eur J Gastroenterol Hepatol 1996; 8:319–323.PubMedGoogle Scholar
  113. 113.
    Fattovich G., Giustina G., Schalm S.W., Hadziyannis S., Sanchez-Tapias J., Almasio P., Christensen E., Krogsgaard K., Degos F., Carneiro de Moura M., et al. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology 1995; 21:77–82.PubMedGoogle Scholar
  114. 114.
    Liaw Y.F., Tai D.I., Chu C.M., Chen T.J. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988; 8:493–496.PubMedGoogle Scholar
  115. 115.
    Chen C.J., Yu M.W., Liaw Y.F. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12:S294–308.PubMedGoogle Scholar
  116. 116.
    Rajagopalan M.S., Busch M.P., Blum H.E., Vyas G.N. Interaction of aflatoxin and hepatitis B virus in the pathogenesis of hepatocellular carcinoma. Life Sci 1986; 39:1287–1290.PubMedGoogle Scholar
  117. 117.
    Buckwold V.E., Ou J.-H. Hepatitis B virus C-gene expression and function: the lessons learned from viral mutants. Current Topics in Virology 1999; 1:71–81.Google Scholar
  118. 118.
    Okada K., Kamiyama I., Inomata M., Imai M., Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976; 294:746–749.PubMedGoogle Scholar
  119. 119.
    Smedile A., Farci P., Verme G., Caredda F., Cargnel A., Caporaso N., Dentico P., Trepo C., Opolon P., Gimson A., Vergani D., Williams R., Rizzetto M. Influence of delta infection on severity of hepatitis B. Lancet 1982; 2:945–947.PubMedGoogle Scholar
  120. 120.
    Govindarajan S., Chin K.P., Redeker A.G., Peters R.L. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 1984; 86:1417–1420.PubMedGoogle Scholar
  121. 121.
    Tassopoulos N.C., Koutelou M.G., Macagno S., Zorbas P., Rizzetto M. Diagnostic significance of IgM antibody to hepatitis delta virus in fulminant hepatitis B. J Med Virol 1990; 30:174–177.PubMedGoogle Scholar
  122. 122.
    Saracco G., Macagno S., Rosina F., Rizzetto M. Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey. Ann Intern Med 1988; 108:380–383.PubMedGoogle Scholar
  123. 123.
    De Cock K.M., Govindarajan S., Chin K.P., Redeker A.G. Delta hepatitis in the Los Angeles area: a report of 126 cases. Ann Intern Med 1986; 105:108–114.PubMedGoogle Scholar
  124. 124.
    Farci P., Smedile A., Lavarini C., Piantino P., Crivelli O., Caporaso N., Toti M., Bonino F., Rizzetto M. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity. Gastroenterology 1983; 85:669–673.PubMedGoogle Scholar
  125. 125.
    Govindarajan S., Hevia F.J. Peters R.L. Prevalence of delta antigen/antibody in B-viral-associated hepatocellular carcinoma. Cancer 1984; 53:1692–1694.PubMedGoogle Scholar
  126. 126.
    Kew M.C., Dusheiko G.M., Hadziyannis S.J., Patterson A. Does delta infection play a part in the pathogenesis of hepatitis B virus related hepatocellular carcinoma?. Br Med J (Clin Res Ed) 1984; 288:1727.Google Scholar
  127. 127.
    Scharschmidt B.F., Held M.J., Hollander H.H., Read A.E., Lavine J.E., Veereman G., McGuire R.F., Thaler M.M. Hepatitis B in patients with HIV infection: relationship to AIDS and patient survival. Ann Intern Med 1992; 117: 837–838.PubMedGoogle Scholar
  128. 128.
    Shakil A.O., Conry-Cantilena C., Alter H.J., Hayashi P., Kleiner D.E., Tedeschi V., Krawczynski K., Conjeevaram H.S., Sallie R., Di Bisceglie A.M. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologie, and histologic features. The Hepatitis C Study Group. Ann Intern Med 1995; 123:330–337.PubMedGoogle Scholar
  129. 129.
    Esteban J.I., Lopez-Talavera J.C., Genesca J., Madoz P., Viladomiu L., Muniz E., Martin-Vega C., Rosell M., Allende H., Vidal X., et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991; 115:443–449.PubMedGoogle Scholar
  130. 130.
    Seeff L.B., Buskell-Bales Z., Wright E.C., Durako S.J., Alter H.J., Iber F.L., Hollinger F., Gitnick G., Knodell R.G., Perrillo R.P., et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med 1992; 327:1906–1911.PubMedGoogle Scholar
  131. 131.
    Fattovich G., Giustina G., Degos F., Tremolada F., Diodati G., Almasio P., Nevens F., Solinas A., Mura D., Brouwer J.T., Thomas H., Njapoum C., Casarin C., Bonetti P., Fuschi P., Basho J., Tocco A., Bhalla A., Galassini R., Noventa F., Schalm S.W., Realdi G. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112:463–472.PubMedGoogle Scholar
  132. 132.
    Kiyosawa K., Sodeyama T., Tanaka E., Gibo Y., Yoshizawa K., Nakano Y., Furuta S., Akahane Y., Nishioka K., Purcell R.H., et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12:671–675.PubMedGoogle Scholar
  133. 133.
    Di Bisceglie A.M., Order S.E., Klein J.L., Waggoner J.., Sjogren M.H., Kuo G., Houghton M., Choo Q.L., Hoofhagle J.H. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gastroenterol 1991; 86:335–338.PubMedGoogle Scholar
  134. 134.
    Koff R.S. Dienstag J.L. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 1995; 15:101–109.PubMedGoogle Scholar
  135. 135.
    Poynard T., Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825–832.PubMedGoogle Scholar
  136. 136.
    Vento S., Garofano T., Renzini C., Cainelli F., Casali F., Ghironzi G., Ferraro T., Concia E. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338:286–290.PubMedGoogle Scholar
  137. 137.
    Chu C.M., Yeh C.T., Liaw Y.F. Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus. Gut 1999; 45:613–617.PubMedGoogle Scholar
  138. 138.
    Weintrub P.S., Veereman-Wauters G., Cowan M.J., Thaler M.M. Hepatitis C virus infection in infants whose mothers took street drugs intravenously. J Pediatr 1991; 119:869–874.PubMedGoogle Scholar
  139. 139.
    Zein N.N. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 2000; 13:223–235.PubMedGoogle Scholar
  140. 140.
    Amoroso P., Rapicetta M., Tosti M.E., Mêle A., Spada E., Buonocore S., Lettieri G., Pierri P., Chionne P., Ciccaglione A.R., Sagliocca L. Correlation between virus genotype and chronicity rate in acute hepatitis C. J Hepatol 1998; 28:939–944.PubMedGoogle Scholar
  141. 141.
    Zein N.N., Rakela J., Krawitt E.L., Reddy K.R., Tominaga T., Persing D.H. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Ann Intern Med 1996; 125:634–639.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Jinah Choi
  • Jing-hsiung Ou
    • 1
  1. 1.Department of Molecular Microbiology & ImmunologyUniversity of Southern California Keck School of MedicineLos AngelesUSA

Personalised recommendations